Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
413 participants
OBSERVATIONAL
2017-01-01
2023-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Frailty Prevalence in Surgical European Patients. European Prospective Cohort Stufy of the Prevalence of Frailty in Surgical Patients.
NCT04140370
Frailty in the Perioperative Period
NCT05893342
Outcome of Very Old Patients Admitted for Elective Major Surgery, the Effect of Frailty
NCT03721471
Frailty and Post-operative Complications in Older Surgical Patients: The Implication of Frailty and Preoperative Risk Assessment
NCT03382054
The Effect of Frailty to Perioperative Complications in the Elderly
NCT04120012
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Methods: prospective cohort study performed at Fundació Puigvert. Enrollment of 850 patients ≥70 y/o who undergo scheduled nephrourologic surgery. In the preoperative visit frailty is going to be evaluated using the Short Physical Performance Battery (SPPB), the Canadian Frailty Scale, the Mini-Cog test (Memory an executive functions), the Pfeiffer Test (Cognitive global screening), an involuntary loss of more than 4.5kg or 5% of weight in the previous year and physical activity using the Metabolic Equivalents of Task (MET). We will analyse the relation among frailty, medical, surgical postoperative complications and mortality at 30 days, 6 months and one year after the surgery.
The results will be adjusted by the possible confounding and interaction variables using a multivariate logistic regression model. The confounding /interaction variables will include demographic data, clinical and lab data and events arisen during the follow-up period.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Signed Informed consent
* 70+ years old
* Scheduled urological surgery with general or regional anesthesia and length of stay in hospital over 24 hours.
* Patients with preserved domiciliary deambulation without aid of another person. (walking sticks, or walkers are accepted)
Exclusion Criteria
* Surgery performed with local anesthetics
* Day surgery, extracorporeal wave lithotripsy or endourological catheterism
* Advanced diagnosed dementia
* Patients with chronic advanced disease or terminal oncological disease
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Parc Sanitari Pere Virgili
OTHER
Fundacio Puigvert
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Merce Prieto Butillé
MD, Anesthesiology consultant
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sergi Sabate, MD PhD
Role: STUDY_DIRECTOR
Chair Anesthesiologist at Fundació Puigvert
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fundació Puigvert
Barcelona, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FRAC1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.